BTSG
BrightSpring Health·NASDAQ
--
--(--)
--
--(--)
BTSG fundamentals
During Q4 2025, BrightSpring Health (BTSG) reported revenue of 3.55B, a YoY change of 29.26%. Net income was 77.32M, a YoY change of 401.95%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 1.98B -- | 1.97B -- | 2.03B -- | 2.17B -- | 2.26B +13.88% | 1.24B -37.11% | 2.29B +12.69% | 2.44B +12.53% | 2.60B +15.28% | 2.75B +121.64% | 2.88B +25.92% | 3.15B +29.10% | 3.33B +28.17% | 3.55B +29.26% | 12.91B -- |
Sales and Services Revenue | 1.98B -- | 1.97B -- | 2.03B -- | 2.17B -- | 2.26B +13.88% | 1.24B -37.11% | 2.29B +12.69% | 2.44B +12.53% | 2.60B +15.28% | 2.75B +121.64% | 2.88B +25.92% | 3.15B +29.10% | 3.33B +28.17% | 3.55B +29.26% | 12.91B -- |
Cost of Revenue | 1.65B -- | 1.63B -- | 1.69B -- | 1.79B -- | 1.90B +15.35% | 1.17B -28.63% | 1.99B +17.69% | 2.13B +18.47% | 2.28B +20.01% | 2.41B +106.64% | 2.54B +27.42% | 2.77B +30.42% | 2.94B +29.14% | 3.14B +30.30% | 11.39B -- |
Cost of Goods and Services | -- -- | 6.37B -- | -- -- | -- -- | 1.90B -- | 1.17B -81.69% | 1.99B -- | 2.13B -- | 2.28B +20.01% | 2.41B +106.64% | 2.54B +27.42% | 2.77B +30.42% | 2.94B +29.14% | 3.14B +30.30% | 11.39B -- |
Gross Profit | 335.75M -- | 337.64M -- | 334.71M -- | 372.07M -- | 358.30M +6.72% | 73.92M -78.11% | 292.49M -12.61% | 312.18M -16.10% | 323.09M -9.83% | 338.67M +358.17% | 338.37M +15.69% | 374.85M +20.08% | 392.01M +21.33% | 412.55M +21.81% | 1.52B -- |
Operating Expenses | 299.60M -- | 314.08M -- | 283.16M -- | 292.45M -- | 410.55M +37.03% | 94.71M -69.85% | 307.83M +8.71% | 273.52M -6.47% | 294.00M -28.39% | 283.13M +198.94% | 287.63M -6.56% | 326.30M +19.29% | 304.17M +3.46% | 304.44M +7.53% | 1.22B -- |
Selling, General and Administrative Expenses | 284.20M -- | 288.62M -- | 283.16M -- | 292.45M -- | 410.55M +44.46% | 94.71M -67.19% | 307.83M +8.71% | 273.52M -6.47% | 294.00M -28.39% | 283.13M +198.94% | 287.63M -6.56% | 326.30M +19.29% | 304.17M +3.46% | 304.44M +7.53% | 1.22B -- |
Loss on Impairment of Other Assets | -- -- | 40.86M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | 15.40M -- | -15.40M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | 36.15M -- | 23.57M -- | 51.55M -- | 79.62M -- | -52.25M -244.55% | -20.79M -188.23% | -15.34M -129.74% | 38.65M -51.45% | 29.10M +155.68% | 55.54M +367.10% | 50.74M +430.87% | 48.56M +25.62% | 87.84M +201.90% | 108.11M +94.66% | 295.25M -- |
Non-Operating Income (Loss) | -63.37M -- | -75.72M -- | -78.18M -- | -79.68M -- | -83.68M -32.05% | -30.36M +59.90% | -67.20M +14.05% | -43.28M +45.68% | -46.61M +44.29% | -46.18M -52.11% | -41.76M +37.85% | -38.78M +10.41% | -38.23M +17.98% | -38.53M +16.55% | -157.31M -- |
Other Non-Operating Income (Loss) | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -12.73M -- | 0 -- | 0 -- | 0 -- | 0 +100.00% | 0 -- | 0 -- | 0 -- | -- -- |
Net Interest Expense | 63.37M -- | 75.72M -- | 78.18M -- | 79.68M -- | 83.68M +32.05% | 30.36M -59.90% | 54.47M -30.32% | 43.28M -45.68% | 46.61M -44.29% | 46.18M +52.11% | 41.76M -23.33% | 38.78M -10.41% | 38.23M -17.98% | 38.53M -16.55% | 157.31M -- |
Pretax Income From Continuing Operations | -27.22M -- | -52.15M -- | -26.62M -- | -68.00K -- | -135.93M -399.38% | -51.15M +1.92% | -82.53M -210.01% | -4.63M -6707.35% | -17.52M +87.11% | 9.36M +118.30% | 8.98M +110.88% | 9.78M +311.26% | 49.61M +383.20% | 69.58M +643.43% | 137.94M -- |
Income Tax Expense | -4.24M -- | 4.53M -- | -4.35M -- | -2.83M -- | -5.81M -36.93% | -18.52M -508.85% | -26.50M -509.85% | -13.12M -362.77% | 8.15M +240.43% | 5.08M +127.41% | -240.00K +99.09% | 1.24M +109.44% | 12.12M +48.62% | 20.03M +294.47% | 33.15M -- |
Current Income Tax | -- -- | 36.43M -- | -- -- | -- -- | -- -- | 16.76M -53.98% | -- -- | -- -- | -- -- | 3.34M -80.05% | -- -- | -- -- | -- -- | 27.60M +725.27% | -- -- |
Deferred Income Tax | -- -- | -27.96M -- | -- -- | -- -- | -- -- | -48.27M -72.63% | -- -- | -- -- | -- -- | -29.73M +38.41% | -- -- | -- -- | -- -- | 5.55M +118.66% | -- -- |
Income from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | 25.43M -- | 9.64M -- | 10.96M -- | 16.69M -- | 11.12M -56.27% | 19.79M +105.29% | 19.00M +73.45% | 17.75M +6.36% | 27.77M +149.68% | 84.32M -- |
Net Income | -22.98M -- | -56.68M -- | -22.28M -- | 2.77M -- | -130.12M -466.27% | -7.20M +87.30% | -46.38M -108.23% | 19.44M +602.86% | -8.98M +93.10% | 15.40M +313.91% | 29.01M +162.54% | 27.54M +41.67% | 55.24M +715.09% | 77.32M +401.95% | 189.11M -- |
Net Income Attributable to Minority Interests | -288.00K -- | -525.00K -- | -894.00K -- | -1.22M -- | 548.00K +290.28% | -664.00K -26.48% | -635.00K +28.97% | -478.00K +60.88% | -751.00K -237.04% | -595.00K +10.39% | -532.00K +16.22% | -666.00K -39.33% | -595.00K +20.77% | 240.00K +140.34% | -1.55M -- |
Net Income Attributable to Owners of the Company | -22.69M -- | -56.16M -- | -21.38M -- | 3.99M -- | -130.67M -475.88% | -6.54M +88.36% | -45.75M -113.97% | 19.92M +399.47% | -8.23M +93.70% | 16.00M +344.75% | 29.54M +164.57% | 28.21M +41.61% | 55.84M +778.44% | 77.08M +381.78% | 190.67M -- |
Net Income Attributable to Common Stockholders | -22.69M -- | -56.16M -- | -21.38M -- | 3.99M -- | -130.67M -475.88% | -6.54M +88.36% | -45.75M -113.97% | 19.92M +399.47% | -8.23M +93.70% | 16.00M +344.75% | 29.54M +164.57% | 28.21M +41.61% | 55.84M +778.44% | 77.08M +381.78% | 190.67M -- |
Other Comprehensive Income | 11.96M -- | 15.40M -- | -10.21M -- | 20.57M -- | 13.05M +9.08% | -32.05M -308.08% | 10.57M +203.53% | -4.09M -119.89% | -19.73M -251.23% | 2.12M +106.62% | -3.29M -131.09% | -2.46M +39.83% | -1.96M +90.06% | -400.00K -118.84% | -8.11M -- |
Total Comprehensive Income | -11.02M -- | -41.28M -- | -32.49M -- | 23.33M -- | -117.08M -962.51% | -39.25M +4.91% | -35.81M -10.24% | 15.35M -34.21% | -28.71M +75.48% | 17.53M +144.65% | 25.72M +171.82% | 25.08M +63.38% | 53.28M +285.57% | 76.92M +338.87% | 181.00M -- |
Total Comprehensive Income Attributable to Minority Interests | -288.00K -- | -525.00K -- | -894.00K -- | -1.22M -- | 548.00K +290.28% | -664.00K -26.48% | -635.00K +28.97% | -478.00K +60.88% | -751.00K -237.04% | -595.00K +10.39% | -532.00K +16.22% | -666.00K -39.33% | -595.00K +20.77% | 240.00K +140.34% | -1.55M -- |
Total Comprehensive Income Attributable to Owners of the Company | -10.73M -- | -40.76M -- | -31.59M -- | 24.56M -- | -117.63M -996.13% | -38.59M +5.32% | -35.18M -11.35% | 15.83M -35.54% | -27.96M +76.23% | 18.12M +146.96% | 26.25M +174.63% | 25.75M +62.66% | 53.88M +292.69% | 76.68M +323.13% | 182.56M -- |
Basic EPS | -- -- | -- -- | -0.18 -- | 0.03 -- | -1.11 -- | -- -- | -0.26 -44.44% | 0.1 +233.33% | -0.04 +96.40% | 0.09 -- | 0.15 +157.69% | 0.14 +40.00% | 0.27 +775.00% | 0.4 +344.44% | 0.96 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -1.11 -- | -- -- | -0.31 -- | 0.05 -- | -0.13 +88.29% | -- -- | 0.05 +116.13% | 0.05 -- | 0.19 +246.15% | -- -- | -- -- |
Basic EPS from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0.05 -- | 0.05 -- | 0.09 -- | -- -- | 0.1 +100.00% | 0.09 +80.00% | 0.08 -11.11% | -- -- | -- -- |
Diluted EPS | -- -- | -- -- | -0.18 -- | 0.03 -- | -1.11 -- | -- -- | -0.26 -44.44% | 0.1 +233.33% | -0.04 +96.40% | -- -- | 0.14 +153.85% | 0.13 +30.00% | 0.26 +750.00% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -1.11 -- | -- -- | -0.31 -- | 0.04 -- | -0.13 +88.29% | -- -- | 0.05 +116.13% | 0.04 -- | 0.17 +230.77% | -- -- | -- -- |
Diluted EPS from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0.05 -- | 0.06 -- | 0.09 -- | -- -- | 0.09 +80.00% | 0.09 +50.00% | 0.09 -- | -- -- | -- -- |
You can ask Aime
What guidance did BrightSpring Health's management provide for the next earnings period?What were the key takeaways from BrightSpring Health’s earnings call?Did BrightSpring Health beat or miss consensus estimates last quarter?What is BrightSpring Health's latest dividend and current dividend yield?What factors drove the changes in BrightSpring Health's revenue and profit?What does BrightSpring Health do and what are its main business segments?What is the revenue and EPS growth rate for BrightSpring Health year over year?What is the market's earnings forecast for BrightSpring Health next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
